Literature DB >> 2435954

[Changes in the blood-cerebrospinal fluid barrier for serum proteins in children with acute lymphatic leukemia].

R Ludwig, R Kretzmann, R Burger, W E Brandeis.   

Abstract

The blood-CSF barrier inhibits permeation of most chemotherapeutic agents into the central nervous system (CNS). The influence of systemic chemotherapy and prohylactic CNS irradiation on the permeability of the blood-CSF barrier was studied in 49 children treated for acute lymphoblastic leukemia (ALL) or non-Hodgkin's lymphoma. To study the permeability of the blood-CSF barrier under treatment according to BFM-ALL protocols, nephelometric determinations of albumin, immunoglobulin G (IgG), and alpha-2-macroglobulin in serum and CSF and total protein in CSF were performed at several time intervals during chemotherapy and prophylactic cranial irradiation. During systemic induction chemotherapy, no significant changes of blood-CSF barrier could be observed. In contrast, in the course of prophylactic CNS irradiation and intrathecal methotrexate application, a significant elevation of albumin, alpha-2-macroglobulin and total protein in CSF, and a significant decrease of blood:CSF ratios for albumin and alpha-2-macroglobulin were observed. IgG did not change significantly. After prophylactic CNS treatment and during maintenance chemotherapy protein concentrations and blood:CSF ratios gradually returned to normal range. This normalization was accelerated by cortisone treatment during the reinduction period.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435954     DOI: 10.1007/bf01745478

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  22 in total

1.  [Blood-brain barrier and the penetration of cytostatic drugs].

Authors:  C Unger; H Eibl; H W von Heyden; B Krisch; G A Nagel
Journal:  Klin Wochenschr       Date:  1985-06-18

2.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

3.  Lipid solubility and drug penetration of the blood brain barrier.

Authors:  W H Oldendorf
Journal:  Proc Soc Exp Biol Med       Date:  1974-12

4.  Protein size and cerebrospinal fluid composition.

Authors:  K Felgenhauer
Journal:  Klin Wochenschr       Date:  1974-12-15

5.  Rapid determination of proteins in serum and cerebrospinal fluid by laser-nephelometry.

Authors:  G Schliep; K Felgenhauer
Journal:  J Clin Chem Clin Biochem       Date:  1978-11

6.  [The quantitative determination of the individual CSF proteins in the diagnosis of inflammatory diseases of the CNS in children (author's transl)].

Authors:  D Karitzky
Journal:  Eur J Pediatr       Date:  1975-12-09       Impact factor: 3.183

7.  Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.

Authors:  E A Neuwelt; P A Barnett; D D Bigner; E P Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

8.  A primate model for study of methotrexate pharmacokinetics in the central nervous system.

Authors:  D G Poplack; W A Bleyer; J H Wood; M Kostolich; J L Savitch; A K Ommaya
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

Review 9.  Histopathology of CNS leukemia and complications of therapy.

Authors:  R A Price
Journal:  Am J Pediatr Hematol Oncol       Date:  1979

10.  Changes of CSF-protein pattern in children with acute lymphoblastic leukemia during prophylactic CNS therapy (Berlin protocol).

Authors:  H Siemes; D Rating; M Siegert; F Hanefeld; S Müller; H Gadner; H Riehm
Journal:  Med Pediatr Oncol       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.